129 related articles for article (PubMed ID: 28991823)
1. Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration.
Meyer NJ; Reilly JP; Anderson BJ; Palakshappa JA; Jones TK; Dunn TG; Shashaty MGS; Feng R; Christie JD; Opal SM
Crit Care Med; 2018 Jan; 46(1):21-28. PubMed ID: 28991823
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of Sepsis Presentations and Mortality Rates.
Biebelberg B; Rhee C; Chen T; McKenna C; Klompas M
Ann Intern Med; 2024 May; ():. PubMed ID: 38801775
[No Abstract] [Full Text] [Related]
3. Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial).
Van Tassell BW; Canada J; Carbone S; Trankle C; Buckley L; Oddi Erdle C; Abouzaki NA; Dixon D; Kadariya D; Christopher S; Schatz A; Regan J; Viscusi M; Del Buono M; Melchior R; Mankad P; Lu J; Sculthorpe R; Biondi-Zoccai G; Lesnefsky E; Arena R; Abbate A
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141858
[TBL] [Abstract][Full Text] [Related]
4. The SPICE III study protocol and analysis plan: a randomised trial of early goaldirected sedation compared with standard care in mechanically ventilated patients.
Shehabi Y; Forbes AB; Arabi Y; Bass F; Bellomo R; Kadiman S; Howe BD; McArthur C; Reade MC; Seppelt I; Takala J; Webb S; Wise MP; ; ;
Crit Care Resusc; 2017 Dec; 19(4):318-326. PubMed ID: 29202258
[TBL] [Abstract][Full Text] [Related]
5. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.
Rudd KE; Johnson SC; Agesa KM; Shackelford KA; Tsoi D; Kievlan DR; Colombara DV; Ikuta KS; Kissoon N; Finfer S; Fleischmann-Struzek C; Machado FR; Reinhart KK; Rowan K; Seymour CW; Watson RS; West TE; Marinho F; Hay SI; Lozano R; Lopez AD; Angus DC; Murray CJL; Naghavi M
Lancet; 2020 Jan; 395(10219):200-211. PubMed ID: 31954465
[TBL] [Abstract][Full Text] [Related]
6. An immune-cell signature of bacterial sepsis.
Reyes M; Filbin MR; Bhattacharyya RP; Billman K; Eisenhaure T; Hung DT; Levy BD; Baron RM; Blainey PC; Goldberg MB; Hacohen N
Nat Med; 2020 Mar; 26(3):333-340. PubMed ID: 32066974
[TBL] [Abstract][Full Text] [Related]
7. Towards personalized medicine: a scoping review of immunotherapy in sepsis.
Slim MA; van Mourik N; Bakkerus L; Fuller K; Acharya L; Giannidis T; Dionne JC; Oczkowski SJW; Netea MG; Pickkers P; Giamarellos-Bourboulis EJ; Müller MCA; van der Poll T; Wiersinga WJ; ; Vlaar APJ; van Vught LA
Crit Care; 2024 May; 28(1):183. PubMed ID: 38807151
[TBL] [Abstract][Full Text] [Related]
8. Highly secreted tryptophanyl tRNA synthetase 1 as a potential theranostic target for hypercytokinemic severe sepsis.
Kim YT; Huh JW; Choi YH; Yoon HK; Nguyen TT; Chun E; Jeong G; Park S; Ahn S; Lee WK; Noh YW; Lee KS; Ahn HS; Lee C; Lee SM; Kim KS; Suh GJ; Jeon K; Kim S; Jin M
EMBO Mol Med; 2024 Jan; 16(1):40-63. PubMed ID: 38177528
[TBL] [Abstract][Full Text] [Related]
9. Targeting the host response in sepsis: current approaches and future evidence.
Bode C; Weis S; Sauer A; Wendel-Garcia P; David S
Crit Care; 2023 Dec; 27(1):478. PubMed ID: 38057824
[TBL] [Abstract][Full Text] [Related]
10. Subphenotypes of Acute Respiratory Distress Syndrome: Advancing Towards Precision Medicine.
Levine AR; Calfee CS
Tuberc Respir Dis (Seoul); 2024 Jan; 87(1):1-11. PubMed ID: 37675452
[TBL] [Abstract][Full Text] [Related]
11. A Targeted Analysis of Serial Cytokine Measures and Nonpulmonary Organ System Failure in Children With Acute Respiratory Failure: Individual Measures and Trajectories Over Time.
Ardila SM; Weeks HM; Dahmer MK; Kaciroti N; Quasney M; Sapru A; Curley MAQ; Flori HR;
Pediatr Crit Care Med; 2023 Sep; 24(9):727-737. PubMed ID: 37195096
[TBL] [Abstract][Full Text] [Related]
12. Model-interpreted outcomes of artificial neural networks classifying immune biomarkers associated with severe infections in ICU.
Martinez GS; Ostadgavahi AT; Al-Rafat AM; Garduno A; Cusack R; Bermejo-Martin JF; Martin-Loeches I; Kelvin D
Front Immunol; 2023; 14():1137850. PubMed ID: 36969221
[TBL] [Abstract][Full Text] [Related]
13. Biological Phenotyping in Sepsis and Acute Respiratory Distress Syndrome.
Sinha P; Meyer NJ; Calfee CS
Annu Rev Med; 2023 Jan; 74():457-471. PubMed ID: 36469902
[TBL] [Abstract][Full Text] [Related]
14. Single-cell transcriptome profiling reveals heterogeneous neutrophils with prognostic values in sepsis.
Hong Y; Chen L; Sun J; Xing L; Yang Y; Jin X; Cai H; Dong L; Zhou L; Zhang Z
iScience; 2022 Nov; 25(11):105301. PubMed ID: 36304125
[TBL] [Abstract][Full Text] [Related]
15. The End of "One Size Fits All" Sepsis Therapies: Toward an Individualized Approach.
Vincent JL; van der Poll T; Marshall JC
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140361
[TBL] [Abstract][Full Text] [Related]
16. Subphenotypes in acute kidney injury: a narrative review.
Vaara ST; Bhatraju PK; Stanski NL; McMahon BA; Liu K; Joannidis M; Bagshaw SM
Crit Care; 2022 Aug; 26(1):251. PubMed ID: 35986336
[TBL] [Abstract][Full Text] [Related]
17. The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia.
Wang W; Gu X; Shao L; Shi Z; Lou G; Song Z; Zhang Y
Contrast Media Mol Imaging; 2022; 2022():2256690. PubMed ID: 35909587
[TBL] [Abstract][Full Text] [Related]
18. New Insights into Clinical and Mechanistic Heterogeneity of the Acute Respiratory Distress Syndrome: Summary of the Aspen Lung Conference 2021.
Martin TR; Zemans RL; Ware LB; Schmidt EP; Riches DWH; Bastarache L; Calfee CS; Desai TJ; Herold S; Hough CL; Looney MR; Matthay MA; Meyer N; Parikh SM; Stevens T; Thompson BT
Am J Respir Cell Mol Biol; 2022 Sep; 67(3):284-308. PubMed ID: 35679511
[TBL] [Abstract][Full Text] [Related]
19. Time- and dose-dependent inhibition of neutrophil extracellular trap formation by blocking of the interleukin-1 receptor.
Wadehn H; Raluy LP; Kolman J; Duecker C; Trochimiuk M; Appl B; Boettcher M; Reinshagen K; Trah J
Cent Eur J Immunol; 2021; 46(4):419-426. PubMed ID: 35125939
[TBL] [Abstract][Full Text] [Related]
20. IL-38 Alleviates Inflammation in Sepsis in Mice by Inhibiting Macrophage Apoptosis and Activation of the NLRP3 Inflammasome.
Ge Y; Chen J; Hu Y; Chen X; Huang M
Mediators Inflamm; 2021; 2021():6370911. PubMed ID: 34955683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
